Bone marrow features and clinical findings in chronic myeloid leukemia - A comparative, multicenter, immunohistological and morphometric study on 614 patients

Leukemia and Lymphoma

Volumn 36, Issue 3-4, 2000, Pages 295-308

  Thiele, Juergen ^a   Kvasnicka, Hans Michael ^b   Schmitt Graeff, Annette ^b   Zirbes, Thomas Karl ^b   Birnbaum, Florian ^b   Kressmann, Christian ^b   Melguizo Grahmann, Manuel ^b   Frackenpohl, Holger ^b   Sprungmann, Claudia ^b   Leder, Lutz Dietrich ^b   Diehl, Volker ^b   Zankovich, Rudolf ^b   Schaefer, Hans Eckart ^b   Niederle, Norbert ^b   Fischer, Robert ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b NONE

Author keywords

Bone marrow biopsies; Chronic myeloid leukemia; Clinicopathologic correlations; Histological features; Laboratory data; Multicenter study; Staging systems; Survival

Indexed keywords

COLLAGEN; GLYCOPHORIN C; HEMOGLOBIN; IRON; MONOCLONAL ANTIBODY; RETICULIN;

ADULT; ANEMIA; ARTICLE; BONE MARROW BIOPSY; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CORRELATION FUNCTION; DISEASE COURSE; ERYTHROBLAST; ERYTHROID PRECURSOR CELL; FEMALE; GERMANY; HEMOGLOBIN SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IRON METABOLISM; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MEGAKARYOPOIESIS; MULTICENTER STUDY; MYELOBLAST; MYELOFIBROSIS; MYELOID METAPLASIA; PERIODIC ACID SCHIFF STAIN; PHILADELPHIA 1 CHROMOSOME; PRECURSOR; PRIORITY JOURNAL; PROGNOSIS; SILVER IMPREGNATION; SPLENOMEGALY;

EID: 0033954341     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009148850     Document Type: Article

References (61)

1. Kantarjian, H.M., Deisseroth, A.S., Kurzrock, R., Estrov, Z. and Talpaz, M.(1993). Chronic myelogenous leukemia: a concise update. Blood. 82, 691-703.
2. Dickstein, J.I., Vardiman and J.W. (1995). Hematopathologic findings in the myeloproliferative disorders. Semin. Oncol., 22, 355-373.
3. Cervantes, F., Rozman and C. (1982). A multivariate analysis of prognostic factors in chronic myeloid leukemia. Blood, 60, 1298-1304.
4. Kantarjian, H.M., Smith, T.L., McCredie, K.B., Keating M.J., Walters, R.S., Talpaz, M., Hester, J.P., Bligham, G., Gehan, E. and Freireich, E.J. (1985). Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival. Blood, 66, 1326-1335.
5. Sokal, J.E., Baccarani, M., Russo, D. and Tura, S. (1988). Staging and prognosis in chronic myelogenous leukemia. Semin. Hematol., 25, 49-61.
6. Cortes, J., Kantarjian, H.M, Giralt, S. and Talpaz, M. (1997). Natural history and staging of chronic myelogenous leukaemia. Baillière's Clin. Haematol., 10, 277-290.
7. Burkhardt, R., Bartl, R., Jaeger, K., Frisch, B., Kettner, G., Mahl, G. and Sund, M. (1984). Chronic myeloproliferative disorders (CMPD). Pathol. Res. Pract., 179, 131-86.
8. Lorand-Metz, I., Vasallo, J. and Souza, C.A. (1987). Histological and cytological heterogeneity of bone marrow in Philadelphia-positive chronic myelogenous leukaemia at diagnosis. Br. J. Haematol., 67, 45-49.
9. Georgii, A., Vykoupil, K.F., Buhr, T., Choritz, H., Döhler, U., Kaloutsi, V and Werner, M. (1990). Chronic myeloproliferative disorders in bone marrow biopsies. Pathol. Res. Pract. 186, 3-27.
10. Thiele, J. and Fischer, R. (1991). Megakaryocytopoiesis in haematological disorders: Diagnostic features of bone marrow biopsies. An overview. Virchows Archiv A Pathol. Anat., 418, 87-97.
11. Nafe, R., Georgii, A., Kaloutsi, V., Fritsch, R.S. and Choritz, H. (1991). Planimetric analysis of megakaryocytes in the four main groups of chronic myeloproliferative disorders. Virchows Archiv B Cell Pathol., 61, 111-116.
12. Thiele, J., Titius, B.R., Kopsidis, C. and Fischer, R. (1992). Atypical micromegakaryocytes, promegakaryoblasts and megakaryoblasts. A critical evaluation by immunohistochemistry and morphometry of bone marrow trephines in chronic myeloid leukemia and myelodysplastic syndromes. Virchows Archiv B Cell Pathol., 62, 275-282,.
13. Buhr, T., Choritz, H. and Georgii, A. (1992). The impact of megakaryocyte proliferation for the evolution of myelofibrosis. Histological follow-up study in 186 patients with chronic myeloid leukemia. Virchows Archiv A Pathol. Anat., 420, 473-478.
14. Bartl, R., Frisch, B. and Wilmanns, W. (1993). Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD). Eur. J. Haematol., 50, 41-52.
15. Dickstein, J.I. and Vardiman, J.W. (1993). Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and the myelodysplastic syndromes. Am. J. Clin. Pathol., 99, 513-25.
16. Gralnick, H.R., Harbor, J. and Vogel, C. (1971). Myelofibrosis in chronic granulocytic leukemia. Blood, 37, 152-162.
17. Clough, V., Geary, C.G., Hashimi, K., Davson, G. and Knowlson, T. (1979). Myelofibrosis in chronic granulocytic leukaemia. Br. J. Haematol., 42, 515-526.
18. Lazzarino, M., Morra, E., Castello, A., Inverardi, D., Coci, A., Pagnuco, G., Magrini, U., Zei, G. and Bernasconi, C. (1986). Myelofibrosis in chronic granulocytic leukemia. Clinical pathologic correlations and prognostic significance. Br. J. Haematol., 64, 227-240.
19. Dekmezian, R., Kantarjian, H.M., Keating, M., Talpaz, M., McCredie, K.B. and Freireich, E.J. (1987). The relevance of reticulin stain-measured fibrosis at diagnosis in chronic myelogenous leukemia. Cancer, 57, 1739-1743.
20. Thiele, J., Kvasnicka, H.M., Titius, B.R., Parpert, U., Nebet, R., Zankovich, R., Dienemann, D., Stein, H., Diehl, V. and Fischer, R. (1993). Histological features of prognostic significance in CML - an immunohistochemical and morphometric study (multivariate regression analysis) on trephine biopsies of the bone marrow. Ann. Hematol., 66, 261-302.
21. Thiele, J., Kvasnicka, H.M., Niederle, N., Kloke, O., Schmidt, M., Lienhard, H., Zirbes, T., Meuter, R.B., Leder, L.D. and Fischer, R. (1995). Clinical and histological features relain their prognostic impact under interferon therapy of CML: a pilot study. Am. J. Hematol., 50, 30-39.
22. Adams, D.O. and Hamilton, T.A. (1984). The cell biology of macrophage activation. Ann. Rev. Immunol., 2, 283-318.
23. Terui, T., Niitsu, Y., Mahara, K., Fujisaki, Y., Urushizaki, Y., Kohogo, Y., Watanabe, N., Ogura, M. and Saito, O. (1990). The production of transforming growth factor-ß in acute megakaryoblastic leukemia and its possible implication in myelofibrosis. Blood, 75, 1540-1548.
24. Reilly, J.T., Barnett, D., Dolan, G., Forrest, P., Eastham, J. and Smith, A. (1993). Characterization of an acute micromegakaryocytic leukemia: evidence for the pathogenesis of myelofibrosis. Br. J. Haematol., 83, 58-62.
25. Rameshwar, P., Denny, T.N., Stein, D. and Gascón, P. (1994). Monocyte adhesion in patients with bone marrow fibrosis is required for the production of fibrogenic cytokines. J. Immunol., 153, 2819-2830.
26. Kimura, A., Katoh, O., Hyodo, H, Kuramoto A. and Satow, Y. (1995). Platelet derived growth factor expression, myelofibrosis and chronic myelogenous leukemia. Leukemia Lymphoma, 18, 237-242.
27. Martyré, M.C. (1995). TGF-β and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders. Leukemia Lymphoma, 20, 39-44.
28. Hayhoe, F.G.J., Flemans, R.J. and Cowling, D.C. (1979). Acquired lipidosis of marrow macrophages. Birefringent blue crystals and Gaucher-like cells, sea-blue histiocytes, and grey-geen crystals. J. Clin Pathol., 32, 420-428.
29. Buesche, G., Majewsk,i H., Schlué, J., Delventhal, S., Baer-Henney, S., Vykoupil, KF, and Georgii, A. (1997). Frequency of Pseudo-Gaucher cells in diagnostic bone marrow biopsies from patients with Ph-positive chronic myeloid leukaemia. Virchows Archiv, 430, 139-148.
30. Albrecht, M. (1972). Ergebnissse von Langzeitbeobachtungen bei Patienten mit chronisch myeloischer Leukämie. In: Leukämie. (Hrsg.) Gross H. van de Loo J., Springer Verlag, Heidelberg, pp 399-404.
31. Kelsey, P.R. and Geary, C.G. (1988). Sea-blue histocytes and Gaucher cells in bone marrow of patients with myeloid leukaemia. J. Clin. Pathol., 41, 960-962.
32. Schaefer, H.E. (1984). How to fix, decalcify and stain paraffin embedded bone marrow biopsies. In: Lennert K; Huebner K. (eds) Pathology of the bone marrow. G. Fischer, Stuttgart. New York. pp 6-9.
33. Gatter, K.C., Cordell, J.L., Turley, H., Heryet, A., Kieffer, N., Anstee, D.J. and Mason, D.Y. (1988). The immunohistological detection of platelets, megakaryocytes and thrombi in routinely processed specimens. Histopathol., 13, 256-267.
34. Falini, B., Flenghi, L., Pileri, S., Gambacorta, M., Bigerna, B., Duerkop, H., Eitelbach, F., Thiele, J., Pacini, R., Cavaliere, A., Martelli, M., Cardelli, N., Sabatini, E., Poggi, S. and Stein, H. (1993). PG-M1. A new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am. J. Pathol., 142, 1359-1372.
35. 4-binding activity. J. Leukocyte. Biol., 45, 452-457.
36. Warfel, A.H. and Zucker-Franklin, D. (1992). Specific ligation of surface α-D-galactosyl epitopes markedly affects the quantity of four major proteins secreted by macrophages. J. Leukocyte. Biol. 52, 80-84.
37. Baldus, S.E., Thiele, J., Park, Y.O., Charles, A., Mross, C., Hanisch, F.G., Zirbes, T.K., Wickenhauser, C. and Fischer, R. (1995). Carbohydrate and peptide antigens in macrophage populations derived from human bone marrow and milk: an immunomorphological and immunohistochemical analysis. Histochem. J., 27, 630-638.
38. Kaplan, E.L. and Meier, P. (1958). Nonparametric estimation from incomplete observations. J. Am. Statist. Ass., 53, 457-481.
39. Sokal, J.E., Cox, E.B., Baccarani, M., Tura, S., Gomez, G.A., Robertson, J.D., Tso, C.Y., Braun, T.J., Clarkson, B.D., Cervantes, F, Rozman, C. and the Italian Cooperative CML Study Group. (1984). Prognostic discrimination in "good-risk" chronic granulocytic leukemia. Blood, 63, 789-799.
40. Kantarjian, H., Keating, M.J., Smith, T.L., Talpaz, M. and McCredie, K.B. (1990). Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemia. Am J. Med., 88, 1-8.
41. Hasford, J., Ansari, H., Pfirrmann, M., Hehlmann, R. and the German CML Study Group. (1996). Analysis and validation of prognostic factors for CML. Bone Marrow Transplant., 17, 49-54.
42. Hehlmann, R., Ansari, H., Hasford, J., Heimpel, H., Hossfeld, D.K., Kolb, H.J. Löffler, H., Pralle, H., Queisser, W., Reiter, A., Hochhaus, A., and the German CML-Study Group. (1997). Comparative analysis of the impact of risk profile and of drug therapy on survival in CML using Sokal's index and a new score. Br. J. Haematol., 97, 76-85.
43. Hasford, J., Pfirrmann, M., Hehlmann, R., Allan, N.C., Baccarani, M., Kluin-Nelemanns, J.C., Alimena, G., Steegmann, J.L. and Ansare, H. (1998). A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. J. Natl. Cancer, Inst., 90, 850-858.
44. Savage, D.G., Szydlo, R.M. and Goldman, J.M. (1997). Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16-year period. Br. J. Haematol., 96, 111-116.
45. O'Brian, S., Kantarjian, H., Shtalrid, M., Blick, M., Beran, M. and Talpaz, M. (1988). Lack of breakpoint cluster region rearrangement in marrow fibroblasts of patients with Philidelphia chromosome-positive chronic myelogenous leukemia. Hematol. Pathol, 2, 25-29.
46. Bhatia, R., McGlave, P.M., Dewald, G.W., Blaza, B.R. and Verfaillie, C.M. (1991). Abnormal function of the bone marrow microinvironment in chronic myelogenous leukemia: role of malignant stromal macrophages. Blood, 85, 3636-3645.
47. Bhatia, R. and Verfaille, C.M. (1998). The effect of interferon-α on beta-1-integrin mediated adhesion and growth regulation in chronic myelogenous leukemia. Leukemia Lymphoma, 28, 241-254.
48. Cervantes, F., Rozman, C., Piera, C. and Fernandez, M.R. (1986). Decreased bone marrow iron in chronic myelogenous leukemia: a consistent finding not reflecting iron deficiency. Blut. 53, 305-308.
49. Sokal, J.E. and Sheerin, K.A. (1986). Decreased stainable marrow iron in chronic granulocytic leukemia. Am. J. Med., 81, 395-399.
50. Maddox, D.E., Shibata, S. and Goldstein, I.J. (1982). Stimulated macrophages express a new glycoprotein receptor reactive with Griffonia simplicifolia I-B4 isolectin. Proc. Natl. Acad Sci. USA. 79, 166-170.
51. Irimura, T., North, S.M. and Nicolson, G.L. (1987). Glycoprotein profiles of macrophages at different stages of activation as revealed by lectin binding after electrophoretic separation. Eur. J. Immunol., 17, 73-78.
52. Obinata, M., Okuyama, R., Matsuda, K.I., Koguma, M. and Yanai, N. (1998). Regulation of myeloid and lymphoid development of hematopoietic stem cells by bone marrow stromal cells. Leukemia Lymphoma, 29, 61-69.
53. Osterholz, J., Dowding, C., Gou, A.P., Siczkowski, M. and Goldman, J.M. (1991). Interferon-α alters the distribution of CFU-GM between the adrerent and non-adherent compartments in long-term cultures of chronic myeloid leukemia marrow. Exp. Hematol., 19, 326-331..
54. Dowding, C., Gou, A.P., Osterholz, J., Siczkowski, M., Goldman, J. and Gordon, M. (1991). Interferon-α overrides the deficient adhesion of chronic myeloid leukemia primitive progenitor cells to bone marrow stromal cells. Blood, 78, 499-505.
55. Golde, D.W., Burgaleta, C., Sparkes, R.S. and Cline, M.J. (1977). The Philadelphia chromosome in human macrophages. Blood, 49, 367-370.
56. Thiele, J., Schmitz, B., Fuchs, R., Kvasnicka, H.M., Lorenzen, J. and Fischer, R. (1998). Detection of the bcr/abl gene in bone marrow macrophages in CML and alterations during interferon therapy - a fluorescence in situ hybridization study on trephine biopsies. J. Pathol., 186, 331-335.
57. Welborn, J.L. and Lewis, J.P. (1993). Correlation of marrow iron pattern with disease status of chronic myelogenous leukemia. Leukemia Lymphoma 10, 469-475.
58. Spiers, A.S.D. (1995). Clinical manifestations of chronic granulocytic leukemia. Semin. Oncol., 22, 380-395.
59. Thiele, J., Hoefer, M, Kvasnicka, H.M., Bertsch, H.P., Zankovich, R. and Fischer, R. (1993). Erythropoiesis in CML -immunohistomorphometric quantification, PCNA-reactivity, and influence on survival. Hematol., Pathol., 7, 239-249.
60. Rozman, C., Cervantes, F. and Feliu, R. (1989). Is the histological classification of chronic granulocytic leukaemia justified from the clinical point of view? Eur. J. Haematol., 42, 150-154.
61. Cervantes, F., Rozman, C. and Feliu, E. (1989). Prognostic evaluation of initial bone marrow histopathological features in chronic granulocytic leukemia. Acta. Haemat., 82, 12-15.